Omar Cook, now the Cleveland Cavalier’s assistant coach is one of those individuals, who as a kid, was part of the Riverside ...

CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

Cantor Fitzgerald analyst Sarah James maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

Steve Nelson, a former chief executive officer of UnitedHealthcare, has been named the president of Hartford-based Aetna, ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...

CVS Health shows signs of recovery and growth potential. Learn why CVS stock is a buy with improved cash flow and strong ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

CVS Health faced mixed results in its latest earnings report, revealing revenue growth amid segment struggles.

The move is one of the first from the new CEO, David Joyner, as he looks to repair the company.

Current health news highlights the expected high demand for Novo Nordisk's obesity drug in India, the need for personalized approaches in knee replacement surgeries, Gilead's notable financial ...

Shares of Medicare-focused health insurers traded higher on Wednesday after Donald J. Trump was elected the 47th President of ...